Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK) Comparison with companies in other sectors?

Jilin Province Huinan Changlong Bio-pharmacy Company Limited has a share price of 585.95M. You can analyze Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK) competitors across different market sectors through stock heatmaps.

What are 8049.HK's NET and operating margins?

Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK) operating margin is around 0.25, and net profit margin is approximately 0.19 as of the latest reports.

In what way does 8049.HK's earnings per share (EPS) trend reflect its financial momentum?

Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK) EPS is 0.36 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Jilin Province Huinan Changlong Bio-pharmacy Company Limited is 6.06, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Jilin Province Huinan Changlong Bio-pharmacy Company Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Jilin Province Huinan Changlong Bio-pharmacy Company Limited like P/E which is 9.38, P/B which is 0.69, and PEG which is 0.53. Compare them with sector averages to evaluate if the stock is priced fairly.

Jilin Province Huinan Changlong Bio-pharmacy Company Limited

8049.HK•HKSE

Healthcare

Drug Manufacturers - Specialty & Generic

HK$2.18

HK$0.00(0.00%)

Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$0.36

P/E Ratio

6.06

ROE

0.08%

Net Margin

0.19%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$1.28B

Shares OutstandingTotal number of shares issued

$585.95M

Book Value/ShareNet worth per share

$2.91

Revenue/ShareAnnual revenue per share

$1.15

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.36

Net MarginNet income as percentage of revenue

18.57%

Operating MarginOperating income as percentage of revenue

25.08%

ROEReturn on shareholders' equity

7.59%

ROAReturn on total assets

4.71%

ROCEReturn on capital employed

9.64%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

$0.96

FCF YieldFree cash flow as percentage of market cap

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.25

Dividend YieldAnnual dividend as percentage of stock price

12.52%

Financial Ratios Analysis data is not available for 8049.HKFinancial Ratios Analysis details for 8049.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for 8049.HKSector Benchmarking details for 8049.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Jilin Province Huinan Changlong Bio-pharmacy Company Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Jilin Province Huinan Changlong Bio-pharmacy Company Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Jilin Province Huinan Changlong Bio-pharmacy Company Limited's unique business strengths and challenges.

Key Financial Metrics for Jilin Province Huinan Changlong Bio-pharmacy Company Limited

For Jilin Province Huinan Changlong Bio-pharmacy Company Limited, essential financial indicators include EPS 0.36, PE 6.06, and ROE 0.08. These key ratios reveal insights into Jilin Province Huinan Changlong Bio-pharmacy Company Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare Jilin Province Huinan Changlong Bio-pharmacy Company Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Jilin Province Huinan Changlong Bio-pharmacy Company Limited

Metrics like Net Margin 18.57% and ROA 4.71% shed light on how well Jilin Province Huinan Changlong Bio-pharmacy Company Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Jilin Province Huinan Changlong Bio-pharmacy Company Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of Jilin Province Huinan Changlong Bio-pharmacy Company Limited

Using ratios such as P/B Ratio 0.69 and PEG Ratio 0.53, investors can assess whether Jilin Province Huinan Changlong Bio-pharmacy Company Limited is appropriately valued based on its financials and growth potential. These figures, combined with Jilin Province Huinan Changlong Bio-pharmacy Company Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Jilin Province Huinan Changlong Bio-pharmacy Company Limited

Financial health indicators, such as Debt/Equity Ratio 0.04 and Cash Flow -, provide a snapshot of Jilin Province Huinan Changlong Bio-pharmacy Company Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Jilin Province Huinan Changlong Bio-pharmacy Company Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Jilin Province Huinan Changlong Bio-pharmacy Company Limited

Investing in Jilin Province Huinan Changlong Bio-pharmacy Company Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Jilin Province Huinan Changlong Bio-pharmacy Company Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;